Clinical Trials on Pertussis

Total 295 results

National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults

Pertussis | Pertussis Immunisation

United States
Sanofi Pasteur, a Sanofi Company

Completed

Effectiveness of Adacel Vaccination in Pregnancy at Preventing Pertussis in Infants < 2 Months of Age in the United States

Pertussis (Whooping Cough)

France
Institut Pasteur
Hopital Universitaire Robert-Debre; Hospices Civils de Lyon; Centre Hospitalier... and other collaborators

Not yet recruiting

Impact of Bacterial Expression and Immune Response in the Severity of Pertussis (PERT-SEVEREII)

Bordetella Pertussis, Whooping Cough

France
ILiAD Biotechnologies

Active, not recruiting

Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children

Bordetella Pertussis, Whooping Cough

United Kingdom, Australia, Costa Rica
University of Turku
GlaxoSmithKline; Sanofi Pasteur, a Sanofi Company

Completed

EUpertstrain 4 Study of Bordetella Pertussis Isolates

Bordetella Pertussis, Whooping Cough

Finland
Institut Pasteur
Agence de Médecine Préventive, France; Institut Pasteur de Madagascar; Institut...

Completed

Pertussis Immunization Programs in Low Income Countries (PERILIC)

Bordetella Pertussis, Whooping Cough

Cambodia, Madagascar, Togo
Institut Pasteur
Sanofi Pasteur, a Sanofi Company; Institut Pasteur of Cote d'Ivoire

Completed

Pertussis Immunization Programs in Low Income Countries - Ivory Coast (PERILIC-IC)

Bordetella Pertussis, Whooping Cough

Côte D'Ivoire
GlaxoSmithKline

Completed

A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary

Pertussis | Pertussis Vaccines

Hungary
University of Southampton

Recruiting

Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks

Pertussis/Whooping Cough

United Kingdom
Association Clinique Thérapeutique Infantile du...
Sanofi; GlaxoSmithKline; Merck Sharp & Dohme LLC

Recruiting

Pediatric Pertussis in Ambulatory Settings (ACTIVCOQ)

Children, Only | Ambulatory | Pertussis/Whooping Cough

France
University Hospital, Ghent
GlaxoSmithKline; Sanofi Pasteur, a Sanofi Company; Novartis Vaccines; University... and other collaborators

Completed

Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses

Prevention of Infections With Bordetella Pertussis

Belgium
University of Virginia

Unknown

Bordetella Pertussis Carriage in College-aged Students

Carriage of Bordetella Pertussis

United States
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058

Tetanus | Diphtheria | Acellular Pertussis | Diphtheria-Tetanus-acellular Pertussis Vaccines

Australia
Groupe d'Etude sur le Risque d'Exposition des Soignants...
Agence Regionale de Sante d'Ile de France; National Agency of Public Health

Completed

GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region (GriCoVax)

Pregnant Women | Influenza Vaccination | Pertussis Vaccine | Healthcare Worker Patient Transmission

France
Gifu Prefecture Medical Association
Sanofi Pasteur S.A.

Completed

Seroepidemiological Study of Pertussis and Other Infectious Diseases

Pertussis Infection

Japan
GlaxoSmithKline

Completed

Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.

Tetanus | Diphtheria | Acellular Pertussis | Diphtheria-Tetanus-acellular Pertussis Vaccines

United States
ILiAD Biotechnologies

Completed

Pertussis Challenge Study in Adults Vaccinated With BPZE1 (CHAMPION-1)

Pertussis/Whooping Cough | Bordetella Pertussis, Whooping Cough

United Kingdom
GlaxoSmithKline

Completed

Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.

Tetanus | Diphtheria | Acellular Pertussis

Germany
Sanofi

Active, not recruiting

Safety of Tetanus, Diphtheria, Acellular Pertussis With 5 Acellular Pertussis Components (Tdap5) Vaccination During Pregnancy

Pertussis (Whooping Cough)

France
Central Hospital, Nancy, France

Completed

Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and Caregivers (COVAGRIP)

Influenza Viral Infections | Pertussis/Whooping Cough

France
Sanofi Pasteur, a Sanofi Company

Completed

Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish Children

Diphtheria, Tetanus and Pertussis

Spain
GlaxoSmithKline

Completed

Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine

Diphteria, Tetanus and Pertussis
GlaxoSmithKline

Completed

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

Tetanus | Diphtheria | Acellular Pertussis

United States
GlaxoSmithKline
Optum, Carolyn Martin and Ami Buikema

Completed

Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants

Tetanus | Diphtheria | Acellular Pertussis
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Finland, Australia, Spain, Italy, Canada, Czechia
GlaxoSmithKline

Completed

Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.

Tetanus | Diphtheria | Acellular Pertussis | Diphtheria-Tetanus-acellular Pertussis Vaccines | Aspergillosis, Allergic Bronchopulmonary

Colombia
GlaxoSmithKline

Terminated

Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia

Diphtheria-Tetanus-Acellular Pertussis

Colombia
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years

Tetanus | Diphtheria | Acellular Pertussis

United States
GlaxoSmithKline

Completed

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.

Tetanus | Diphtheria | Acellular Pertussis

Finland
GlaxoSmithKline

Completed

Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®

Tetanus | Diphtheria | Acellular Pertussis
GlaxoSmithKline

Completed

Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine

Tetanus | Diphtheria | Acellular Pertussis

United States
CanSino Biologics Inc.

Active, not recruiting

A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)

Diphtheria, Tetanus and Acellular Pertussis

China
GlaxoSmithKline

Completed

Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea

Diphtheria-Tetanus-acellular Pertussis Vaccines

Korea, Republic of
GlaxoSmithKline

Completed

Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects

Diphtheria-Tetanus-acellular Pertussis Vaccines

Russian Federation
Sanofi Pasteur, a Sanofi Company

Completed

A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada

Tetanus Immunisation (Healthy Volunteers) | Diphtheria Immunisation (Healthy Volunteers) | Pertussis Immunisation (Healthy Volunteers)

Canada
GlaxoSmithKline

Completed

Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea

Tetanus | Diphtheria | Acellular Pertussis | Diphtheria-Tetanus-acellular Pertussis Vaccines | Poliomyelitis

Korea, Republic of
GlaxoSmithKline

Completed

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Finland, Australia, Spain, Italy, Canada, Czechia
GlaxoSmithKline

Completed

Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Poliomyelitis Vaccines

Singapore
GlaxoSmithKline

Completed

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

Tetanus | Diphtheria | Acellular Pertussis

United States
Duke University
Centers for Disease Control and Prevention

Completed

Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

Pertussis | Influenza Vaccine | Papillomavirus Infection

United States
Central Hospital, Nancy, France

Unknown

Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born Neonates (VacciPrema)

Hib Immunisation in Very Preterm-born Infants | Pertussis Immunisation in Very Preterm-born Infants

France
GlaxoSmithKline

Completed

Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Diphtheria-Tetanus-aPertussis-Poliomyelitis-Haemophilus Influenzae Type b Vaccines

Vietnam
GlaxoSmithKline

Completed

Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children

Hepatitis B | Tetanus | Diphtheria | Haemophilus Influenzae Type b | Whole Cell Pertussis | Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin

Thailand, Philippines
GlaxoSmithKline

Completed

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

Hepatitis B | Tetanus | Diphtheria | Haemophilus Influenzae Type b | Whole Cell Pertussis | Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccin

Thailand
London School of Hygiene and Tropical Medicine
Radboud University Medical Center; University of Turku; Imperial College London; University of Oxford and other collaborators

Active, not recruiting

Gambia Pertussis Study (GaPs) (GaPs)

Pertussis

Gambia
University of Oxford
University of Turku; National Institute for Public Health and the Environment...

Completed

A Study Exploring Whooping Cough Protection in Children and Adults (BERT)

Pertussis

United Kingdom, Finland, Netherlands
Siegrist Claire-Anne
BioNet-Asia Co., Ltd.

Completed

The PertADO Geneva Trial

Pertussis

Switzerland
Institut National de la Santé Et de la Recherche...
European Union; Swedish Institute for Infectious Disease Control; Innogenetics

Completed

First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine

Pertussis

Sweden
Université de Reims Champagne-Ardenne

Not yet recruiting

Knowledge of Pregnant Women Concerning Pertussis, Vaccination Against Pertussis and Cocooning Strategy (Coqueluche-Vac)

Pertussis
Scientific and practical center of sanitary and...

Unknown

Seroprevalence of Pertussis Among Healthy Children and Adolescents in Kazakhstan

Pertussis

Kazakhstan

Clinical Trials on Pertussis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations